Associations of microvascular complications with all‐cause death in patients with diabetes and <scp>COVID</scp> ‐19: The <scp>CORONADO</scp> , <scp>ABCD</scp> COVID‐19 UK national audit and <scp>AMERICADO</scp> study groups
Samy Hadjadj(Université de Poitiers), Renée Pekmezaris(Feinstein Institute for Medical Research), Pierre‐Jean Saulnier(Inserm), Yue Ruan(University of Oxford), Rustam Rea(University of Oxford), Alyson K. Myers(Northwell Health), Pierre Gourdy(Université Toulouse III - Paul Sabatier), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Kamlesh Khunti(University of Leicester), Michel Marre(Centre National de la Recherche Scientifique), Matthieu Wargny(Centre National de la Recherche Scientifique), Bertrand Cariou(Institut du Thorax), Xu Zhu(Feinstein Institute for Medical Research)
Cited by 6
Related Papers
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
2. Classification and Diagnosis of Diabetes:<i>Standards of Care in Diabetes—2023</i>
|Diabetes Care|2022|2.4k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k
Sex differences in metabolic regulation and diabetes susceptibility
|Diabetologia|2019|876
9. Pharmacologic Approaches to Glycemic Treatment: <i>Standards of Care in Diabetes—2023</i>
|Diabetes Care|2022|850